Translational Health Science And Technology Institute (THSTI), has now been recognized by CEPI as one of the Global network of Laboratories for centralized assessment of COVID 19 Vaccines.
- The THSTI is an autonomous institute of the Department of Biotechnology, Government of India.
- The CEPI network will initially involve six labs, one each in Canada, Britain, Italy, the Netherlands, Bangladesh and India.
- Under the CEPI Global network the Laboratory will use the same reagents and follow a common set of protocols to measure the immune response of multiple vaccine candidates under development and trial.
- The Ind-CEPI mission for establishment of BSL-3 facility, is a translational laboratory for platform technologies and a Bioassay laboratory for development of assays to measure clinical immunogenicity.
- The mandate of the bioassay laboratory at THSTI is to provide validated assays for vaccine development on par with global standards.
- The Department of Biotechnology, Ministry of Science & Technology, and Government of India has been implementing the IndCEPI mission ‘India Centric Epidemic Preparedness through Rapid Vaccine Development.
- CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to develop vaccines to stop future epidemics.
(Source: PIB)
CLICK HERE FOR UPSC PRELIMS CURRENT AFFAIRS MCQ
